





Cervical Cytology: Automatic recognition of 15 cell types; Sensitivity ≥ 95%, Specificity ≥ 85%.
Thyroid Cytology: Automatic recognition of 6 cell types; Sensitivity ≥ 95%, Specificity ≥ 90%.
Urine Cytology: Recognition of high-grade uroepithelial cancer cells based on TPS standard.
Hydrothorax & Ascites: Recognition of malignant tumor cells; Sensitivity ≥ 96%.
Gastric & Intestinal: Covers >95% of lesion types; combines gastroscopy/colonoscopy history.
Cervical & Endometrial: Automatic identification of squamous and adenocarcinomas; rapid localization of lesions.
Lymph Node Metastasis: Generates heat maps for lesion localization; reduces underdiagnosis of micrometastatic lesions.
Immunohistochemistry: Intelligent cell counting and area segmentation; Accuracy > 0.94.
Integrating 5G and cloud computing to support synchronous online slide reading, online annotation, and multi-screen collaborative linkage for complex cases.
A collaborative research platform focusing on deep learning algorithms, pathogenomics, and radiomics for medical research entities.





We are a high-tech, innovative healthcare provider equipped with robust AI computing power and big data platforms. We are dedicated to providing AI-driven digital healthcare services and intelligent solutions for the global healthcare sector.
Our expertise covers clinical care, rehabilitation, and In Vitro Diagnostics (IVD), with a focus on surgical procedures, neurosurgical brain-computer interfaces, AI-powered rehabilitation robots, and AI-enhanced pathological auxiliary diagnosis.



